Freelance writer for Salon.com
Katie Engelhart on KCRW
More from KCRW
Illegal mining in Brazil: Danger for locals, resources for tech companies
EnvironmentPeople are illegally mining the Amazon rainforest for gold and tin ore. Some of those elements are going to Google and Apple. The mines are threatening Indigenous communities.
Own a fraction of a home? Californians raise concerns
Housing & DevelopmentEmploying what it calls “fractional ownership” for second homes, real estate startup Pacaso has left communities scrambling to regulate its model.
To infinity and beyond with JPL’s new director
ScienceLaurie Leshin, JPL’s new director, wants to explore the far reaches of space, find evidence of life on Mars, and make the institution more inclusive.
LA’s 60-year effort to protect city’s history, cultural heritage
HistoryWho says Angelenos don’t care about history? Since the Leonis Adobe became Cultural Monument No. 1 in LA, the city has designated more than 1,000 others.
Death doulas want to be your guides to dying well
Health & WellnessDying is a complicated process. Death doulas want to make it better. That can mean helping with your will, spiritual issues, or just a great going-away party.
Fist bumping the dictator we pretend to love
InternationalFormer Mideast CIA operative John Kiriakou discusses his recent trip covering Biden in Saudi Arabia and what he’s learned about America’s “special relationship” with the country.
South LA doctor stretches monkeypox vax, hopes to accommodate walk-ups
Health & WellnessLA County has so far identified more than 600 monkeypox cases. The low vaccine supply makes it tough to get doses to Latino and Black communities with limited health care access.
Renovated Hollyhock House: Flower motif, art glass, Maya stonework
DesignThe 5,000-square-foot Hollyhock House in East Hollywood was renovated during COVID, and on August 18, it’ll reopen to the public.
Limitations of the Inflation Reduction Act of 2022
Health & WellnessThe new legislation offers some major successes, but with regard to drug pricing it is not close to what it could have been.